Shaundra Clay's most recent trade in Integra Lifesciences Holdings Corp was a trade of 19,592 Common Stock done . Disclosure was reported to the exchange on May 9, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Integra Lifesciences Holdings Corp | Shaundra D. Clay | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 May 2025 | 19,592 | 41,515 (0%) | 0% | 0 | Common Stock | |
| Integra Lifesciences Holdings Corp | Shaundra Clay | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 May 2024 | 8,696 | 21,923 (0%) | 0% | 0 | Common Stock | |
| Integra Lifesciences Holdings Corp | Shaundra Clay | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 May 2023 | 4,486 | 13,227 (0%) | 0% | 0 | Common Stock | |
| Integra Lifesciences Holdings Corp | Shaundra Clay | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 May 2022 | 3,456 | 8,741 (0%) | 0% | 0 | Common Stock | |
| Integra Lifesciences Holdings Corp | Shaundra Clay | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 May 2022 | 1,265 | 5,285 (0%) | 0% | 0 | Common Stock | |
| Integra Lifesciences Holdings Corp | Shaundra Clay | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 May 2021 | 2,896 | 4,020 (0%) | 0% | 0 | Common Stock | |
| Integra Lifesciences Holdings Corp | Shaundra Clay | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 May 2021 | 1,060 | 1,124 (0%) | 0% | 0 | Common Stock | |
| Integra Lifesciences Holdings Corp | Shaundra Clay | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 May 2021 | 64 | 64 (0%) | 0% | 0 | Common Stock |